Stock Price
95.65
Daily Change
2.74%
Yearly
35.48%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Aurora Cannabis Inc 5.10 -0.02 -0.39% -65.84%
ANI Pharmaceuticals 40.72 -0.28 -0.68% 37.94%
Aphria Inc 16.55 -0.98 -5.59% 225.79%
Bristol-Myers Squibb 63.75 1.51 2.42% 2.34%
Corcept Therapeutics 16.63 -0.53 -3.09% -42.08%
Catalent 97.07 -1.06 -1.08% -15.51%
Endo International Ordinary Shares 3.08 -0.01 -0.16% -58.33%
GlaxoSmithKline 1,677.20 45.40 2.78% 20.91%
GW Pharmaceuticals 218.96 0 0% 108.53%
Horizon Pharma 87.33 -0.08 -0.09% 19.42%
Jazz Pharmaceuticals 135.44 2.42 1.82% -17.04%
Lannett 1.44 -0.01 -0.69% -82.92%
Eli Lilly 236.47 -1.39 -0.58% 12.54%
Merck & Co 80.79 1.65 2.08% 3.68%
Nektar Therapeutics 10.67 0.02 0.19% -42.14%
Novartis 79.67 1.51 1.93% -3.82%
Novo Nordisk A Fs 95.65 2.55 2.74% 35.48%
Phibro Animal Health 19.18 -0.05 -0.26% -8.45%
Prestige Brands 56.77 0.68 1.21% 39.76%
Pacira 61.02 -0.54 -0.88% -8.83%
Powershares High Yield Orate Bond Portfolio 18.84 -0.08 -0.40% -2.56%
Perrigo 38.09 0.08 0.21% -12.82%
Drreddys Laboratories 55.92 -2.17 -3.74% -15.35%
Sanofi 94.89 2.95 3.21% 19.98%
Supernus Pharmaceuticals 29.11 -0.24 -0.82% -3.48%
Teva Pharmaceutical Industries 8.26 -0.15 -1.78% -32.57%
United States Oil Fund 61.80 0.12 0.19% 75.32%
Bausch Health Companies Inc 30.13 -0.08 -0.26% -8.53%
Canopy Growth Corp 8.85 -0.29 -3.17% -82.83%
Zoetis 188.47 -1.37 -0.72% 20.41%


Novo Nordisk A Fs
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.